Giredestrant (Standard)

(Synonyms: GDC-9545 (Standard); RG6171 (Standard))

Giredestrant (Standard) (GDC-9545 (Standard); RG6171 (Standard)) is the analytical standard of Giredestrant (HY-109176). This product is intended for research and analytical applications. Giredestrant (GDC-9545) is an orally active, full, selective Estrogen receptor α (ERα) degrader and antagonist with a DC50 of 0.03 nM. Giredestrant promotes the degradation of ERα protein, including the ESR1Y537S mutant ERα. Giredestrant reduces uterine wet weight in immature rats and induces a low cuboidal phenotype in their endometrial epithelium. Giredestrant induces tumor regression in both ESR1Y537S mutant and wild-type ERα tumor models. Giredestrant can be used for the research of ER+ breast cancer.

For research use only. We do not sell to patients.

  • CAS No.: 1953133-47-5
  • Formula: C27H31F5N4O
  • Molecular Weight:522.55
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Product Information
  • Chemical Information
  • Purity & Documentation
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00